Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Coronary Flow Reserve and Inflammation in HIV-Positive Patients
NCT02234492Phase 4Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Sep 2014
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in cardiovascular disease (CVD), sponsored by University of Ottawa Heart Institute. Started Sep 2014; status: completed.
02
Drugs
rosuvastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02234492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234492.